Waist-to-height ratio: An accurate anthropometric index of abdominal adiposity and a predictor of high HOMA-IR values in nondialyzed chronic kidney disease patients

Nutrition

Volumn 30, Issue 3, 2014, Pages 279-285

  Barreto Silva, Maria Inês ^a   Lemos, Carla Cavalheiro da Silva ^a   Torres, Márcia Regina Simas Gonçalves ^a   Bregman, Rachel ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Abdominal adiposity; Anthropometric indices; Chronic kidney disease; Insulin resistance; Receiver operating characteristics; Waist to height ratio

Indexed keywords

ABDOMINAL ADIPOSITY; ANTHROPOMETRIC INDICES; CHRONIC KIDNEY DISEASE; INSULIN RESISTANCE; RECEIVER-OPERATING CHARACTERISTICS; WAIST-TO-HEIGHT RATIO;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; AGED; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CROSS-SECTIONAL STUDIES; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY, ABDOMINAL; OVERWEIGHT; RENAL INSUFFICIENCY, CHRONIC; ROC CURVE; TRIGLYCERIDES; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84893345674     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.08.004     Document Type: Article

References (55)

1. Low S., Chin M.C., Deurenberg-Yap M. Review on epidemic obesity. Ann Acad Med Singapore 2009, 38:57-65.
2. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009, 53:1925-1932.
3. Després J.-P. Abdominal obesity and cardiovascular disease: is inflammation the missing link?. Can J Cardiol 2012, 28:642-652.
4. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infaction in 27,000 participants from 52 countries: a case-control study. Lancet 2005, 366:1640-1649.
5. Canoy D., Boekholdt S.M., Wareham N., Luben R., Welch A., Bingham S., et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation into Cancer and Nutrition in Norfolk Cohort. A population-based prospective study. Circulation 2007, 116:2933-2943.
6. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
7. Ginsberg H.N. Insulin resistance and cardiovascular disease. J Clin Invest 2000, 106:453-458.
8. Reaven G.M. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am 2011, 95:875-892.
9. Fox K.A.A., Després J.P., Richar A.J., Brette S., Deanfield J.E. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91 246 ambulant patients in 27 European countries. Eur Heart J 2009, 30:3055-3063. IDEA Steering Committee and National Co-ordinators.
10. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Supplements 2013, 3:1-150.
11. Obermayr R.P., Temml C., Knechtelsdorfer M., Gutjahr G., Kletzmayr J. Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 2008, 23:1265-1273.
12. Zhang Q.L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008, 8:117.
13. Kobayashi S., Maesato K., Moriya H., Ohtake T., Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005, 45:275-280.
14. Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC. Insulin resistance in patients with chronic kidney disease [E-pub ahead of print] J Biomed Biotechnol doi: doi:10.1155/2012/691369.
15. Shinohara K., Shoji T., Emoto M., Tahara H., Koyama H., Ishimura E., et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am SocNephrol 2002, 13:1894-1900.
16. Becker B., Kronenberg F., Kielstein J.T., Haller H., Morath C., Ritz E., et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005, 16:1091-1098.
17. Banerjee D., Recio-Mayoral A., Chitalia N., Kaski J.C. Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients. Clin Cardiol 2011, 34:360-365.
18. Di Angelantonio E., Chowdhury R., Sarwar N., Aspelund T., Danesh J., Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 2010, 341:c4986.
19. Cupisti A., D'Alessandro C., Morelli E., Rizza G.M., Galetta F., Franzoni F., et al. Nutritional status and dietary manipulation in predialysis chronic renal failure patients. J Ren Nutr 2004, 14:127-133.
20. Dumler F., Kilates C. Prospective nutritional surveillance using bioelectrical impedance in chronic kidney disease patients. J Ren Nutr 2005, 15:148-151.
21. Silva M, Vale B, Lemos C, Torres M, Bregman R. Body adiposity index assess body fat with high accuracy in nondialyzed chronic kidney disease patients [E-pub ahead of print]. Obesity (Silver Spring) doi: doi:10.1038/oby.2012.174.
22. McCullough P.A., Steigerwalt S., Tolia K., Chen S.C., Li S., Norris K.C., Whaley-Connell A. Cardiovascular Disease in Chronic Kidney Disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep 2011, 11:47-55. on behalf of the KEEP Investigators.
23. Parikh N.I., Hwang S.J., Larson M.G., Meigs J.B., Levy D., Fox C.S. Cardiovascular disease risk factors in chronic kidney disease overall burden and rates of treatment and control. Arch Intern Med 2006, 166:1884-1891.
24. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. Global burden of metabolic risk factors of chronic diseases collaborating group (body mass index): national, regional, and global trends in body mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
25. Heymsfield S.B., Wang Z., Baumgartner R.N., Ross R. Human body composition: advances in models and methods. Annu Rev Nutr 1997, 17:527-558.
26. Perk J., De Backer G., Gohlke H., Graham I. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012, 33:1635-1701.
27. World Health Organization. Waist Circumference and Waist-Hip Ratio Report of a WHO Expert Consultation Geneva,2008.
28. Sanches F.M., Avesani C.M., Kamimura M.A., Lemos M.M., Axelsson J., Vasselai P., et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 2008, 52:66-73.
29. Bazanelli A.P., Kamimura M.A., Manfredi S.R., Draibe S.A., Cuppari L. Usefulness of waist circumference as a marker of abdominal adiposity in peritoneal dialysis: a cross-sectional and prospective analysis. Nephrol Dial Transplant 2012, 27:790-795.
30. Velludo C.M., Kamimura M.A., Sanches F.M., Lemos M.M., Canziani M.E., Pupim L.B., et al. Prospective evaluation of waist circumference and visceral adipose tissue in patients with chronic kidney disease. Am J Nephrol 2010, 31:104-109.
31. Lin C.H., Chou C.Y., Lin C.C., Huang C.C., Liu C.S., Lai S.W. Waist-to-height ratio is the best index of obesity in association with chronic kidney disease. Nutrition 2007, 23:788-793.
32. Dobbelsteyn C.J., Joffres M.R., MacLean D.R., Flowerdew G. The Canadian Heart Health Surveys Research Group. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes 2001, 25:652-661.
33. Shiwaku K., Anuurad E., Enkhmaa B., Nogi A., Kitajima K., Yamasaki M., et al. Predictive values of anthropometric measurements for multiple metabolic disorders in Asian populations. Diabetes Res Clin Pract 2005, 69:52-62.
34. Ho S.Y., Lam T.H., Janus E.D. Waist to stature ratio is more strongly associated with cardiovascular risk factors than other simple anthropometric indices. Ann Epidemiol 2003, 13:683-691.
35. Lin W.Y., Lee L.T., Chen C.Y., Lo H., Hsia H.H., Liu I.L., et al. Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 2002, 26:1232-1238.
36. Pitanga F.J.G., Llessa I. Razão cintura-estatura como discriminador do risco coronariano de adultos. Rev Assoc Med Bras 2006, 52:157-161.
37. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000, 35:S1-140. Clinical practice guidelines for nutrition in chronic renal failure.
38. World Health Organization. Physical status: the use and interpretation of anthropometry-Report of a WHO Expert Committee -WHO Technical Report Series 854, Geneva,1995.
39. Frisancho A.R. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981, 34:2540-2545.
40. Lohman T.J. Advances in body composition Assessment: current issues in exercise science series 1992, HumanKinectics, Champaign, IL.
41. Fouque D., Kalantar-Zadeh K., Kopple J., Cano N., Chauveau P., Cuppari L., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008, 73:391-398.
42. Composition of foods. Raw, processed, prepared, agriculture handbook, No. 8 1976, United States Department of Agriculture, series 1-16, revised, National Agriculture Library, Beltsville, MD.
43. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment insulin resistence and b-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985, 28:412-419.
44. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
45. The new IASO/IOTF analysis (2010): International Association for the Study of Obesity (IASO) January 2013. Available at: Accessed March 10,2013. http://www.iaso.org/iotf/obesity/obesitytheglobalepidemic.
46. Instituo Brasileiro de Geografia e estatística. Pesquisa de Orçamentos Familiares-POF 2008-2009. Available at: Accessed March 10,2013. http://www.ibge.gov.br.
47. Leite-Cavalcanti Mda C., Rodrigues-Gonçalves C, Rios-Asciutti L.S., Leite-Cavalcanti A. The prevalence of chronic disease in a group of elderly Brazilian people and their nutritional status. Rev Salud Publica 2009, 11:865-877.
48. Schelbert K.B. Comorbidities of obesity. Prim Care 2009, 36:271-285.
49. Balkau B., Deanfield J.E., Després J.P., Bassan J.P., Fox K.A.A., Smith S.C., et al. InternationalDay for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007, 116:1942-1951.
50. Casanueva F.F., Moreno B., Rodríguez-Azeredo R., Massien C., Conthe P., Formiguera X., et al. Relationship of abdominal obesity with cardiovascular disease, diabetes andhyperlipidaemia in Spain. Clin Endocrinol (Oxf) 2010, 73:35-40.
51. Lee C.M., Huxley R.R., Wildman R.P., Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 2008, 61:646-653.
52. He Y.H., Chen Y.C., Jiang G.X., Huang H.E., Li R., Li X.Y., Ning G., et al. Evaluation of anthropometric indices for metabolic syndrome in Chinese adults aged 40 years and over. Eur J Nutr 2012, 51:81-87.
53. Li C., Engstrom G., Hedblad B., Calling S., Berglund G., Janzon L. Sex differences in the relationships between BMI, WHR and incidence of cardiovascular disease: a population-based cohort study. Int J Obes (Lond) 2006, 30:1775-1781.
54. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008, 359:2105-2120.
55. Pitanga F.J.G. Anthropometry for the assessment of abdominal obesity andcoronary risk. Rev Bras Cineantropom Desempenho Hum 2011, 13:238-241.